Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Who will Theralase partner with?
View:
Post by Eoganacht on Aug 29, 2024 12:03pm

Who will Theralase partner with?

Roger Dumoulin-White quote from yesterday's video.

"I think that we take a page book out of the pharma companies. And what they do is, they tend to partner. So they have their drug, they tend to partner with other pharmaceutical companies and say "Hey, let's do a combinational study. We have our drug you have your drug. Let's put them together and see if we get a synergistic effect." We would take that same playbook. So we have our drug - we develop it. So our next step is really what's called a GLP toxicology study, which allows us to do testing to set the human equivalent dose etc...what's safe in patients and what's effective etc." 
 
"So we plan to do that in fourth quarter, subject, of course, to having the funds to cover that. With that information though, it would provide us with an ability to inject our drug into human patients in a phase 1 clinical study. From there it becomes exciting because other pharmaceutical companies, knowing the data that we produced on this pre-clinical model would say, "Well, how about we combine it with our drug and see what happens for this condition, or we combine it with this other drug and see what happens?" So it opens up a whole bunch of partnering opportunities, which I think would be very important for the company." 

Theralase Explores Synergistic Drug Combinations for Cancer Treatment
Comment by Tarbaby on Aug 29, 2024 2:55pm
 GOOD PLANS ROGER.. Doing the GLP toxicology study plus partnering with big pharma are the best plans going forward. To follow up and capitalize on all the recent lab work with Rutherrin showing how it potentiates other csncer drugs. And be sure bid Pharma pays for the JOINT STUDIES..
Comment by DJDawg on Aug 29, 2024 3:09pm
They have been doing GLP work for a while now and Dr. Mandel is a strong scientist. He has been doing the Rutherrin work for a while so if they are pivoting to do a metformin + rutherrin + xray activation trial then hopefully it is just a bit of add on work to show no harmful interactions. Metformin is an approved drug already so don't need to prove anything with it. Perhaps they just need to ...more  
Comment by Alamir1111 on Aug 29, 2024 3:24pm
I think dr Mandels  salary should be around 600000$ for work his doing. Being paid the same amount as an accountant is a bit off 
Comment by Alamir1111 on Aug 29, 2024 5:12pm
Any bets on pp heard should close Friday? I would say 350000$? Hope I'm wrong
Comment by Tarbaby on Aug 30, 2024 3:32pm
I want any money I put in to a PP to go strictly into lab work and none to pay big huge salaries.. They should drastically reduce big salaries until success comes..like a BIG PHARMA cash input..based on the lab wirk paid for by the risk takers buying into private placements. And I want to see more PP money coming from the highly paid managers and insiders. Otherwise we risk taking investors are ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250